Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715507 · ClinicalTrials.gov registry record
Evaluation of Drug Display in Critical Care Setting
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 200
- Enrollment target
NCT00715507: Completed study, sponsored by University of Utah.
NCT00715507 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00715507 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.
Interventions
- DEVICE medication monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-07 |
| Est. Completion | 2012-08 |
What the finished NCT00715507 record still lists
NCT00715507 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which medication monitor is the first listed.
NCT00715507 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00715507 about?
NCT00715507 is a clinical study titled "Evaluation of Drug Display in Critical Care Setting". To assess the clinical utility of the graphical medication monitor, results of the anesthetics for which the display was present will be compared to the results of the anesthetics in which there was no display.
What is the current status of trial NCT00715507?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2003-07. Estimated completion is 2012-08.
What interventions are being tested in trial NCT00715507?
The interventions under investigation include: medication monitor (DEVICE).
Who is sponsoring clinical trial NCT00715507?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia